Page last updated: 2024-11-13

tetraphenylporphine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tetraphenylporphyrin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID86280046
CHEMBL ID436524
CHEMBL ID3039846
CHEBI ID52279
SCHEMBL ID30136
MeSH IDM0142242

Synonyms (66)

Synonym
AKOS002375245
5,10,15,20-tetraphenyl-21h,23h-prophine
NCI60_013368
nsc-640184
.alpha.,.gamma.,.delta.-tetraphenylporphine
21h, 5,10,15,20-tetraphenyl-
tetraphenylporphyrin
porphine,10,15,20-tetraphenyl-
meso-tetraphenylporphine
5,15,20-tetraphenylporphine
917-23-7
meso-tetraphenylporphyrin
nsc18506
tetraphenylporphine
nsc-18506
(5z,10z,14z,19z)-5,10,15,20-tetraphenyl-21,23-dihydroporphyrin
5,10,15,20-tetraphenyl-21h,23h-porphine
nsc640184
meso-tetra(phenyl)porphine
20998-75-8
5,10,15,20-tetraphenyl-21h,23h-porphine, >=99%
5,10,15,20-tetraphenyl-21h,23h-porphine, 97%
CHEBI:52279 ,
5,10,15,20-tetraphenylporphyrin
meso-tetraphenylporphyrin, suitable for fluorescence, bioreagent, >=99.0% (hplc)
CHEMBL436524 ,
T1359
nsc 640184
nsc 18506
porphine, 5,10,15,20-tetraphenyl- (van)
5,10,15,20-tetraphenylporphine
sdb2sh8g5k ,
21h,23h-porphine, 5,10,15,20-tetraphenyl-
meso-tetraphenylporphin
einecs 213-025-9
unii-sdb2sh8g5k
meso-tetraphenylporphyrine
SCHEMBL30136
5,10,15,20-tetrakis(phenyl)porphyrin
YNHJECZULSZAQK-UHFFFAOYSA-N
DTXSID2061272
STR04536
2,7,12,17-tetraphenyl-21,22,23,24-tetraazapentacyclo[16.2.1.1^{3,6}.1^{8,11}.1^{13,16}]tetracosa-1,3,5,7,9,11(23),12,14,16,18(21),19-undecaene
5,10,15,20-tetraphenyl-21h,23h-porphyrin
.alpha.,.beta.,.gamma.,.delta.-tetraphenylporphine
porphine, 5,10,15,20-tetraphenyl-
YNHJECZULSZAQK-LWQDQPMZSA-N
CHEMBL3039846
mfcd00011680
meso-tetraphenylporphine, low chlorin
CS-0022009
SY009714
bdbm50247512
F14722
BCP21699
meso-tetraphenylporphyrine pound>>5,10,15,20-tetraphenylporphyrin
tpp; tetraphenylporphine
5,10,15,20-(tetraphenyl)porphyrin
tetraphenylporphyrin (chlorin free)
meso-tetraphenylporphyrin, 97%
HY-103656
5,10,15,20-tetraphenyl-21,23-dihydroporphyrin
porphine, alpha,beta,gamma,delta-tetraphenyl-
tpp (chelating agent)
EN300-7405378
tetraphenylporphryin

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" For PCI to be developed further, it is important to understand whether nerve damage is an impending side effect when treating cancers within or adjacent to nervous system tissue."( Could clinical photochemical internalisation be optimised to avoid neuronal toxicity?
Hopper, C; MacRobert, AJ; O'Rourke, C; Phillips, JB; Woodhams, JH, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
DNA topoisomerase 1Homo sapiens (human)EC50 (µMol)50.00000.05000.33592.0150AID1472923; AID1472924
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (11)

Processvia Protein(s)Taxonomy
DNA topological changeDNA topoisomerase 1Homo sapiens (human)
chromatin remodelingDNA topoisomerase 1Homo sapiens (human)
circadian rhythmDNA topoisomerase 1Homo sapiens (human)
response to xenobiotic stimulusDNA topoisomerase 1Homo sapiens (human)
programmed cell deathDNA topoisomerase 1Homo sapiens (human)
phosphorylationDNA topoisomerase 1Homo sapiens (human)
peptidyl-serine phosphorylationDNA topoisomerase 1Homo sapiens (human)
circadian regulation of gene expressionDNA topoisomerase 1Homo sapiens (human)
embryonic cleavageDNA topoisomerase 1Homo sapiens (human)
chromosome segregationDNA topoisomerase 1Homo sapiens (human)
DNA replicationDNA topoisomerase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA bindingDNA topoisomerase 1Homo sapiens (human)
chromatin bindingDNA topoisomerase 1Homo sapiens (human)
double-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
single-stranded DNA bindingDNA topoisomerase 1Homo sapiens (human)
RNA bindingDNA topoisomerase 1Homo sapiens (human)
DNA topoisomerase type I (single strand cut, ATP-independent) activityDNA topoisomerase 1Homo sapiens (human)
protein serine/threonine kinase activityDNA topoisomerase 1Homo sapiens (human)
protein bindingDNA topoisomerase 1Homo sapiens (human)
ATP bindingDNA topoisomerase 1Homo sapiens (human)
DNA binding, bendingDNA topoisomerase 1Homo sapiens (human)
protein domain specific bindingDNA topoisomerase 1Homo sapiens (human)
supercoiled DNA bindingDNA topoisomerase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
nuclear chromosomeDNA topoisomerase 1Homo sapiens (human)
P-bodyDNA topoisomerase 1Homo sapiens (human)
fibrillar centerDNA topoisomerase 1Homo sapiens (human)
male germ cell nucleusDNA topoisomerase 1Homo sapiens (human)
nucleusDNA topoisomerase 1Homo sapiens (human)
nucleoplasmDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
perikaryonDNA topoisomerase 1Homo sapiens (human)
protein-DNA complexDNA topoisomerase 1Homo sapiens (human)
nucleolusDNA topoisomerase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1853100Induction of singlet oxygen production in DMSO assessed as singlet oxygen quantum yield by measuring the photooxidation of 9,10-dimethylanthracene at 5 uM irradiated with 50 W LED light2022RSC medicinal chemistry, Dec-14, Volume: 13, Issue:12
Synthesis and evaluation of radiolabeled porphyrin derivatives for cancer diagnoses and their nonradioactive counterparts for photodynamic therapy.
AID1195999Singlet oxygen generation of the compound exposed to 4.2 mW/cm2 light energy density assessed as singlet oxygen quantum yield measured at at 410 nm in 10 seconds intervals of irradiation at 0.2 uM by DPBF scavenger based assay2015European journal of medicinal chemistry, Mar-06, Volume: 92Synthesis, characterization and in vitro photodynamic antimicrobial activity of basic amino acid-porphyrin conjugates.
AID1472923Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells using supercoiled pBS SK(+) DNA as substrate after 15 mins by ethidium bromide staining based agarose gel electrophoresis method2018Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3
Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
AID1336590Phototoxicity against human HaCaT cells assessed as cell viability at 1 uM after irradiation with light at 180 J/cm'2 for 30 mins by MTT assay2017Bioorganic & medicinal chemistry letters, 01-15, Volume: 27, Issue:2
Photodynamic effect of meso-(aryl)porphyrins and meso-(1-methyl-4-pyridinium)porphyrins on HaCaT keratinocytes.
AID1472924Inhibition of recombinant human topoisomerase-1 expressed in baculovirus infected sf9 cells using supercoiled pBS SK(+) DNA as substrate preincubated for 5 mins followed by substrate addition measured after 15 mins by ethidium bromide staining based agaro2018Journal of medicinal chemistry, 02-08, Volume: 61, Issue:3
Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
AID1196000Octanol water partition coefficient, log P of the compound by reverse-phase thin-layer chromatography2015European journal of medicinal chemistry, Mar-06, Volume: 92Synthesis, characterization and in vitro photodynamic antimicrobial activity of basic amino acid-porphyrin conjugates.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (272)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (1.84)18.7374
1990's6 (2.21)18.2507
2000's116 (42.65)29.6817
2010's127 (46.69)24.3611
2020's18 (6.62)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 42.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index42.69 (24.57)
Research Supply Index5.65 (2.92)
Research Growth Index5.42 (4.65)
Search Engine Demand Index61.97 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (42.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.36%)5.53%
Reviews1 (0.36%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other279 (99.29%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]